Regulation of Mammalian mRNA Decay

哺乳动物 mRNA 衰变的调控

基本信息

  • 批准号:
    10387387
  • 负责人:
  • 金额:
    $ 5.56万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2004
  • 资助国家:
    美国
  • 起止时间:
    2004-09-01 至 2023-02-28
  • 项目状态:
    已结题

项目摘要

Summary of the funded parental grant GM067005: The control of mRNA stability is a critical determinant in the post-transcriptional regulation of eukaryotic gene expression. Even minor alterations in mRNA stability can have profound consequences and may manifest as clinical phenotypes as illustrated by the ability of aberrantly expressed proto-oncogenes that can give rise to malignancies. Eukaryotic mRNAs are generally thought to possess an N7 methyl guanosine (m7G) cap at their 5¢ end to promote their stability and translation. However, our recent demonstration that mammalian mRNAs can also carry a 5´-end nicotinamide adenine dinucleotide (NAD) cap that in contrast to the m7G cap promotes mRNA decay, provides a new paradigm for mRNA 5´ end processing and the contribution of nucleotide metabolites in mRNA turnover. We now demonstrate that the redox state of NAD can also modulate 3´ RNA decay with free NAD functioning as a cofactor to enhance RNA decay and potentially providing a link to cellular energetics. Moreover, flavin adenine diphosphate (FAD) can also serve as a 5´ cap on mammalian RNAs with Nudt16 and DXO hydrolases functioning as proteins that can remove the FAD cap (deFADding) in vitro. We will build on these novel findings throughout this proposal within three specific aims. The first will address the functional role of free NAD on the control of 3´ end RNA decay in vitro and delineate the molecular mechanism involved in its stimulation of decay. The second will deduce changes in mRNA decay as a consequence of altered NAD levels in cells and assess the regulatory role imparted by stress conditions in modulating RNA decay through the control of NAD levels. In the last aim, we establish FAD cap as an alternative RNA cap, identify FAD-capped RNAs and decipher the role of FAD caps and the deFADding enzymes in cells. Collectively, the proposed studies will provide insight into a heretofore unknown fundamental post-transcriptional regulatory mechanism and will provide the framework for potential novel avenues to control gene expression in normal and disease states.
获资助的父母补助金GM067005摘要:

项目成果

期刊论文数量(42)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
The RNA binding protein HuR determines the differential translation of autism-associated FoxP subfamily members in the developing neocortex.
  • DOI:
    10.1038/srep28998
  • 发表时间:
    2016-07-07
  • 期刊:
  • 影响因子:
    4.6
  • 作者:
    Popovitchenko T;Thompson K;Viljetic B;Jiao X;Kontonyiannis DL;Kiledjian M;Hart RP;Rasin MR
  • 通讯作者:
    Rasin MR
BAY11 enhances OCT4 synthetic mRNA expression in adult human skin cells.
  • DOI:
    10.1186/scrt163
  • 发表时间:
    2013-02-06
  • 期刊:
  • 影响因子:
    7.5
  • 作者:
    Awe JP;Crespo AV;Li Y;Kiledjian M;Byrne JA
  • 通讯作者:
    Byrne JA
5' End Nicotinamide Adenine Dinucleotide Cap in Human Cells Promotes RNA Decay through DXO-Mediated deNADding.
  • DOI:
    10.1016/j.cell.2017.02.019
  • 发表时间:
    2017-03-09
  • 期刊:
  • 影响因子:
    64.5
  • 作者:
    Jiao X;Doamekpor SK;Bird JG;Nickels BE;Tong L;Hart RP;Kiledjian M
  • 通讯作者:
    Kiledjian M
DcpS as a therapeutic target for spinal muscular atrophy.
  • DOI:
    10.1021/cb800120t
  • 发表时间:
    2008-11-21
  • 期刊:
  • 影响因子:
    4
  • 作者:
    Singh J;Salcius M;Liu SW;Staker BL;Mishra R;Thurmond J;Michaud G;Mattoon DR;Printen J;Christensen J;Bjornsson JM;Pollok BA;Kiledjian M;Stewart L;Jarecki J;Gurney ME
  • 通讯作者:
    Gurney ME
Structure and function of pre-mRNA 5'-end capping quality control and 3'-end processing.
  • DOI:
    10.1021/bi401715v
  • 发表时间:
    2014-04-01
  • 期刊:
  • 影响因子:
    2.9
  • 作者:
    Jurado AR;Tan D;Jiao X;Kiledjian M;Tong L
  • 通讯作者:
    Tong L
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MEGERDITCH KILEDJIAN其他文献

MEGERDITCH KILEDJIAN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MEGERDITCH KILEDJIAN', 18)}}的其他基金

5’ end RNA Caps in Gene Expression
基因表达中的 5 端 RNA 帽
  • 批准号:
    10622778
  • 财政年份:
    2023
  • 资助金额:
    $ 5.56万
  • 项目类别:
Eukaryotic RNA NAD capping and deNADding
真核 RNA NAD 加帽和 deNADding
  • 批准号:
    10443996
  • 财政年份:
    2018
  • 资助金额:
    $ 5.56万
  • 项目类别:
Eukaryotic RNA NAD capping and deNADding
真核 RNA NAD 加帽和 deNADding
  • 批准号:
    10797880
  • 财政年份:
    2018
  • 资助金额:
    $ 5.56万
  • 项目类别:
Eukaryotic RNA NAD capping and deNADding
真核 RNA NAD 加帽和 deNADding
  • 批准号:
    10622526
  • 财政年份:
    2018
  • 资助金额:
    $ 5.56万
  • 项目类别:
Regulation of Mammalian mRNA Decapping
哺乳动物 mRNA 脱帽的调控
  • 批准号:
    7271916
  • 财政年份:
    2004
  • 资助金额:
    $ 5.56万
  • 项目类别:
Regulation of Mammalian mRNA Decapping
哺乳动物 mRNA 脱帽的调控
  • 批准号:
    9068973
  • 财政年份:
    2004
  • 资助金额:
    $ 5.56万
  • 项目类别:
Regulation of Mammalian mRNA Decapping
哺乳动物 mRNA 脱帽的调控
  • 批准号:
    6821604
  • 财政年份:
    2004
  • 资助金额:
    $ 5.56万
  • 项目类别:
Regulation of Mammalian mRNA Decapping
哺乳动物 mRNA 脱帽的调控
  • 批准号:
    8729092
  • 财政年份:
    2004
  • 资助金额:
    $ 5.56万
  • 项目类别:
Regulation of Mammalian mRNA decapping
哺乳动物 mRNA 脱帽的调控
  • 批准号:
    7729816
  • 财政年份:
    2004
  • 资助金额:
    $ 5.56万
  • 项目类别:
Regulation of Mammalian mRNA Decay
哺乳动物 mRNA 衰变的调控
  • 批准号:
    10350594
  • 财政年份:
    2004
  • 资助金额:
    $ 5.56万
  • 项目类别:

相似海外基金

The Role of Adenine Nucleotide Translocase in Mitochondrial Dysfunction Associated Senescence in Chronic Obstructive Pulmonary Disease (COPD)
腺嘌呤核苷酸转位酶在慢性阻塞性肺病(COPD)线粒体功能相关衰老中的作用
  • 批准号:
    10633608
  • 财政年份:
    2023
  • 资助金额:
    $ 5.56万
  • 项目类别:
Pathways of Succinate Accumulation and Adenine Nucleotide Depletion in Cardiac Ischemia
心脏缺血中琥珀酸积累和腺嘌呤核苷酸消耗的途径
  • 批准号:
    10534031
  • 财政年份:
    2022
  • 资助金额:
    $ 5.56万
  • 项目类别:
Pathways of Succinate Accumulation and Adenine Nucleotide Depletion in Cardiac Ischemia
心脏缺血中琥珀酸积累和腺嘌呤核苷酸消耗的途径
  • 批准号:
    10794933
  • 财政年份:
    2022
  • 资助金额:
    $ 5.56万
  • 项目类别:
Development of nobel assay methods for miRNA and adenine methyltransferase using FRET
使用 FRET 开发 miRNA 和腺嘌呤甲基转移酶的诺贝尔检测方法
  • 批准号:
    21K05120
  • 财政年份:
    2021
  • 资助金额:
    $ 5.56万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Critical assessment of DNA adenine methylation in brain cells from healthy aging and Alzheimer's disease
健康老龄化和阿尔茨海默病脑细胞 DNA 腺嘌呤甲基化的批判性评估
  • 批准号:
    10365337
  • 财政年份:
    2021
  • 资助金额:
    $ 5.56万
  • 项目类别:
DNA Methylation at N6-Adenine in Placental Trophoblast Development
胎盘滋养层发育中 N6-腺嘌呤 DNA 甲基化
  • 批准号:
    10033546
  • 财政年份:
    2020
  • 资助金额:
    $ 5.56万
  • 项目类别:
DNA Methylation at N6-Adenine in Placental Trophoblast Development
胎盘滋养层发育中 N6-腺嘌呤 DNA 甲基化
  • 批准号:
    10613902
  • 财政年份:
    2020
  • 资助金额:
    $ 5.56万
  • 项目类别:
DNA Methylation at N6-Adenine in Placental Trophoblast Development
胎盘滋养层发育中 N6-腺嘌呤 DNA 甲基化
  • 批准号:
    10396102
  • 财政年份:
    2020
  • 资助金额:
    $ 5.56万
  • 项目类别:
DNA Methylation at N6-Adenine in Placental Trophoblast Development
胎盘滋养层发育中 N6-腺嘌呤 DNA 甲基化
  • 批准号:
    10226235
  • 财政年份:
    2020
  • 资助金额:
    $ 5.56万
  • 项目类别:
DNA Methylation at N6-Adenine in Placental Trophoblast Development
胎盘滋养层发育中 N6-腺嘌呤 DNA 甲基化
  • 批准号:
    10705982
  • 财政年份:
    2020
  • 资助金额:
    $ 5.56万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了